PLANT HEALTH CARE PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.72 GBX | -2.62% |
|
-3.63% | +0.81% |
| Apr. 22 | Plant Health Care hails Harpinab approval in Belgium | AN |
| Apr. 22 | Plant Health Care's Fertilizer Receives Belgian Approval | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.66 for the current period. Therefore, the company is undervalued.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +0.81% | 15.95M | - | ||
| +1.67% | 15.17B | B+ | ||
| -14.18% | 15.06B | D+ | ||
| +6.58% | 12.61B | C | ||
| -13.63% | 9.92B | B+ | ||
| -11.60% | 7.34B | A- | ||
| -.--% | 7.21B | - | C- | |
| -3.50% | 4.25B | B- | ||
| -27.17% | 2.43B | D | ||
| +2.63% | 2.07B | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PHC Stock
- Ratings Plant Health Care plc
